
    
      Hemodialysis patients over 18 years were recruited after fulfilling the inclusion
      criteria.Seventy-one hemodialysis patients were randomized into two groups: the trial group
      (n =35 ) and the controls (n =36 ); a randomization numeric table was used for allocation
      sequence . Trial group received turmeric and control group received placebo for 12 weeks.
      Biochemical determinations included levels of serum albumin (Alb), potassium (K) ,blood urea
      nitrogen (BUN), serum creatinine (Cr), IL-6 level, TNF- Î± , and liver function tests and
      hs-CRP at the start and end of the study were measured.
    
  